WO2013030794A3 - Use of substituted pyridines as skin depigmenting compounds - Google Patents

Use of substituted pyridines as skin depigmenting compounds Download PDF

Info

Publication number
WO2013030794A3
WO2013030794A3 PCT/IB2012/054488 IB2012054488W WO2013030794A3 WO 2013030794 A3 WO2013030794 A3 WO 2013030794A3 IB 2012054488 W IB2012054488 W IB 2012054488W WO 2013030794 A3 WO2013030794 A3 WO 2013030794A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
substituted pyridines
skin depigmenting
depigmenting compounds
compounds
Prior art date
Application number
PCT/IB2012/054488
Other languages
French (fr)
Other versions
WO2013030794A2 (en
Inventor
Behrooz Kasraee
Original Assignee
Behrooz Kasraee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behrooz Kasraee filed Critical Behrooz Kasraee
Publication of WO2013030794A2 publication Critical patent/WO2013030794A2/en
Publication of WO2013030794A3 publication Critical patent/WO2013030794A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

The present invention relates to skin and/or hair depigmentation compositions comprising a pyridine derivative and dermatologically acceptable carriers. The skin and/or hair depigmentation compositions can also comprise cysteamine hydrochloride. The present invention also relates to the cosmetic and pharmaceutical use thereof for reducing skin and/or hair pigmentation.
PCT/IB2012/054488 2011-08-31 2012-08-31 Use of substituted pyridines as skin depigmenting compounds WO2013030794A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1425/11 2011-08-31
CH14252011 2011-08-31

Publications (2)

Publication Number Publication Date
WO2013030794A2 WO2013030794A2 (en) 2013-03-07
WO2013030794A3 true WO2013030794A3 (en) 2013-12-27

Family

ID=47116122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/054488 WO2013030794A2 (en) 2011-08-31 2012-08-31 Use of substituted pyridines as skin depigmenting compounds

Country Status (1)

Country Link
WO (1) WO2013030794A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6880011B2 (en) * 2015-10-05 2021-06-02 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin whitening composition
EP3471692B1 (en) * 2016-06-15 2019-10-30 Unilever N.V. Method and cosmetic composition for enhanced transdermal delivery of alkyl substituted resorcinol
RS58997B1 (en) * 2018-09-14 2019-08-30 Fazlagic Amira Dr Composition against aging of the intimate area skin
WO2021249760A1 (en) 2020-06-10 2021-12-16 Unilever Ip Holdings B.V. A cosmetic composition comprising 6-methyl-picolinamide
WO2021260667A2 (en) 2020-06-26 2021-12-30 Universidade Do Minho Composition for hair follicle modulation, methods and uses thereof
WO2022208123A1 (en) * 2021-03-30 2022-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating hyperpigmentation disorders
WO2024056568A1 (en) * 2022-09-12 2024-03-21 Behrooz Kasraee Skin depigmentation composition and use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057184A2 (en) * 2001-12-28 2003-07-17 Integriderm, Inc. Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners
JP2004123554A (en) * 2002-09-30 2004-04-22 Pias Arise Kk Substance for improving skin barrier function, substance for ameliorating skin wrinkle, skin care preparation for external use, cosmetic and quasi-drug comprising the same substance
EP1649852A1 (en) * 2003-07-16 2006-04-26 Institute of Medicinal Molecular Design, Inc. Chromatosis remedies
US20100015072A1 (en) * 2008-06-30 2010-01-21 Christopher Polla Topical Compositions Comprising Isonicotinamide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057184A2 (en) * 2001-12-28 2003-07-17 Integriderm, Inc. Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners
JP2004123554A (en) * 2002-09-30 2004-04-22 Pias Arise Kk Substance for improving skin barrier function, substance for ameliorating skin wrinkle, skin care preparation for external use, cosmetic and quasi-drug comprising the same substance
EP1649852A1 (en) * 2003-07-16 2006-04-26 Institute of Medicinal Molecular Design, Inc. Chromatosis remedies
US20100015072A1 (en) * 2008-06-30 2010-01-21 Christopher Polla Topical Compositions Comprising Isonicotinamide

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Iproniazid", WIKIPEDIA, 28 July 2013 (2013-07-28), pages 1 - 2, XP055076767, Retrieved from the Internet <URL:http://de.wikipedia.org/wiki/Iproniazid> [retrieved on 20130828], DOI: 10.1016/0006-2952(86)90285-6 *
ANONYMOUS: "Nialamide", 26 May 2013 (2013-05-26), pages 1 - 2, XP055076772, Retrieved from the Internet <URL:http://en.wikipedia.org/wiki/Nialamide> [retrieved on 20130828], DOI: 10.1111/j.1365-2133.1977.tb15180.x *
D. G. GRAY ET AL.: "Clinico-Laboratory Studies of Alpha-ethylthioisonicotinamide (TH 1314)", CANAD. MED. ASS. J., vol. 86, 1962, pages 317 - 320, XP055076770 *
FOURCHE JEANNE ET AL: "INTERFERENCE DE DERIVES DE L'HYDRAZINE SUR LA REACTION TYROSINASE-TYROSINE//Interference of hydrazine derivatives on the tyrosinase-tyrosine reaction", COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DESSCIENCES. SERIES D, SCIENCES NATURELLES, GAUTHIER-VILLARS, PARIS, FR, vol. 287, no. 4, 11 September 1978 (1978-09-11), pages 365 - 368, XP009172100, ISSN: 0567-655X *
LEIGH MIYAMOTO, JAMES S. TAYLOR: "Chapter 32. Chemical Leukoderma", 2000, Blackwell Science Ltd, Oxford, UK, pages 269 - 280, XP002711905, ISBN: 0-632-05071-3, Retrieved from the Internet <URL:http://onlinelibrary.wiley.com/doi/10.1002/9780470760116.ch32/pdf> *
S. S. BLEEHEN ET AL.: "Depigmentation of skin with 4-isopropylcatechol, mercaptoamines, and other compounds", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 50, no. 2, 1968, pages 103 - 117, XP002711904 *

Also Published As

Publication number Publication date
WO2013030794A2 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
WO2013030794A3 (en) Use of substituted pyridines as skin depigmenting compounds
PT2734180T (en) Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013025765A3 (en) Methods of reducing odor
PL3176156T3 (en) Alkylamidothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin
HK1141454A1 (en) A cosmetic composition for skin whitening comprising the extract of magnolia sieboldii as active ingredient
PL2549979T3 (en) Cosmetic or dermatological preparations with a content of one or more thiazole derivatives
WO2011122869A3 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
EP2797595A4 (en) A nutritional approach to the use of ergothioneine and vitamin d2 for hair, nail and skin growth
PT2552397T (en) Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate and a vitamin a compound
IL231050A0 (en) Substituted 4,5,6,7-terahydro1h-pyrazolo[4,3-c]pyridines,their use as medicament,and pharmaceutical preparations comprising them
PL2758383T3 (en) Aromatic amidothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin
IT1395122B1 (en) COMPOSITION FOR PHARMACEUTICAL OR COSMETIC OR DIETETIC USE PERFORMING A HAIR PIGMENTATION EFFECT
WO2012116990A3 (en) Novel use
WO2013002518A3 (en) Skin care kit comprising cosmetic compound and application method for the cosmetic compound
WO2012161497A3 (en) Peptide derivatives having a superior moisturizing effect and uses thereof
WO2011021892A3 (en) Composition for skin improvement comprising hexamidines and retinoids
WO2013109388A3 (en) 1,5-naphthyridine derivatives and melk inhibitors containing the same
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
PL2758382T3 (en) Heterocyclocarbonylaminothiazoles, cosmetic and dermatological preparations containing them, and their use for the treatment and prophylaxis of unwanted pigmentation of the skin
PL2593097T3 (en) Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them
WO2012020070A3 (en) Enhancement of the skin depigmentation
WO2012128971A3 (en) Topical acyl glutathione formulations
EP2641894A4 (en) Glycin derivatives inhibiting melanin production and whitening composition thereof
WO2008125237A3 (en) Use of vernonia appendiculata extract for improving the skin status
IL225879A0 (en) Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

Legal Events

Date Code Title Description
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/07/2014)

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/07/2014)

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12780534

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12780534

Country of ref document: EP

Kind code of ref document: A2